NASDAQ OMX

Sigma Designs Names New Z-Wave Certification Test House in China

Dela

 

The Institute of Digital Guangdong to Provide Independent Technical Certification

FREMONT, Calif., Oct. 10, 2017 (GLOBE NEWSWIRE) -- Sigma Designs® (NASDAQ:SIGM), a leading provider of intelligent system-on-chip (SoC) solutions for Connected Smart TV platforms and Smart home IoT, today announces the Institute of Digital Guangdong (IDG) will serve as a new Z-Wave Certification Test House in China, to expand certification testing capabilities in Asia.

Z-Wave Certification ensures interoperability between Z-Wave products. All Z-Wave products must be certified before launch on the commercial market and once certified, will display Z-Wave interoperability logo badges. There are two components to Z-Wave certification. Technical certification is managed through Sigma Designs utilizing independent, third-party test houses and Market Certification is managed through the Z-Wave Alliance.

"We know the smart home market has great potential in China. We have chosen to work with IDG to better serve the growing Z-Wave market and give our customers who are creating smart home experiences in China a quicker path to certification and thus the commercial market," said Raoul Wijgergangs, VP of Sigma Designs' Z-Wave Business Unit.

Sigma Designs currently has approximately 340 companies registered on the Z-Wave Plus Certification Portal, representing 35 different countries. At least 40 of those companies are from mainland China and five from Hong Kong.

"As a new certification facility, we are excited to promote the use of the Z-Wave technology in the market and are committed to facilitating the industrial deployment of the Z-Wave technology," said Dr. Li Ying, Executive Vice President of IDG.

IDG will serve as the independent, third-party technical certification test house in China beginning Oct. 9. This expands the global presence of authorized test partners and gives developers the option of using BuLogics in Philadelphia Pennsylvania, Pepper-One in Zwickau Germany and now, IDG in Guangzhou China for technical certification.

About Sigma Designs
Sigma Designs, Inc. (NASDAQ:SIGM) is a world leader in enabling smart home convergence. The company designs and builds the essential semiconductor technologies that serve as the foundation for the world's leading Connected Smart TV platforms, and Internet of Things (IoT) for smart home devices. For more information about Sigma Designs, please visit www.sigmadesigns.com.

About Z-Wave
Z-Wave technology is an open internationally recognized ITU standard (G.9959). It is the leading wireless home control technology in the market today, with over 2100 certified interoperable products worldwide. Represented by the Z-Wave Alliance, and supported by more than 600 companies around the world, the standard is a key enabler of smart living solutions for home safety and security, energy, hospitality, office and light commercial applications.

Z-Wave® is a registered trademark of Sigma Designs and its subsidiaries in the United States and other countries.

About IDG
Institute of Digital Guangdong (IDG), the South China Branch of Institute of Digital China in Peking University (IDC/PKU), was founded in April 2009 as a provincial public service institution to provide experience and support for the vision of digital technology, industry and economy in China.

Under the guidance of IDC/PKU and the Economic and Information Commission of Guangdong Province, IDG is dedicated to Digital Guangdong and Digital China development by bridging government bodies, industrial sectors, academic communities and research institutions, with a focus on consultancy and research, application promotion, industrial development, talent training, and international cooperation.

Currently, IDG also serves as the Secretariat of the Guangdong RFID Standards Commission, responsible for the daily operation of the institution.

Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including statements about consumer adoption, and the anticipated features and benefits of Sigma's products and solutions with respect to Z-Wave and various Z-Wave offerings. Actual results may vary materially due to a number of factors including, but not limited to, consumer and customer acceptance of Z-Wave and Z-Wave new test house provider, Sigma's ability to deploy and achieve market acceptance for Sigma's products in its target markets, including the IoT market, the relative success of the new test house provider, the overall ability Z-Wave development kit, chipsets and modules to compete with other technologies or products in these markets as well as other risks that are detailed from time to time in Sigma's SEC reports, including its report on Form 10-K. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Sigma undertakes no obligation to publicly release or otherwise disclose any revision to these forward-looking statements that may be made as a result of events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

Press Contacts:
Mary Miller                                                                  Alexandra Crabb        
Sigma Designs                                                           Caster Communications
+1-510-897-1069                                                        +1-401-792-7080
Mary_Miller@sigmadesigns.com                               alex@castercomm.com

 
 



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Sigma Designs, Inc. via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

Raven Indusries Releases CR12(TM) Field Computer18.6.2018 16:49Pressmeddelande

12-Inch Display With Field Planning Features Helps Farmers Save Time and Increase Efficiencies MIDDENMEER, The Netherlands, June 18, 2018 (GLOBE NEWSWIRE) -- Raven Industries (NASDAQ:RAVN) announced today the release of a new, larger field computer: the CR12(TM). Utilizing the same powerful functionality as the CR7(TM) field computer, the CR12 offers an extensive field planning feature for increased efficiencies. Built with a durable magnesium waterproof housing and a full glass capacitive touchscreen with high brightness, the CR12 also boasts a wider, 12.1-inch display. The CR12 joins the CR7 as the latest field computer in the CRX display family. This powerful operating system features easy job set-up, fewer touches and greater efficiencies - empowering the user with extraordinary data management capabilities. A simple widget concept, easily accessible settings, and ISO Universal Terminal and Task Controller capabilities make this mighty unit an affordable, plug-and-play system. Like

FPGA programming solution goes live at AEE 2018 in latest version of SLX18.6.2018 15:00Pressmeddelande

Silexica / FPGA programming solution goes live at AEE 2018 in latest version of SLX . Processed and transmitted by Nasdaq Corporate Solutions. The issuer is solely responsible for the content of this announcement. Industry-first solution fully explores the design space to optimize hardware/software partitioning SLX automatically inserts pragmas and rewrites code to make it High-Level Synthesis (HLS) ready Solution designed in collaboration with customers including Ricoh SAN JOSE, Calif. and COLOGNE, Germany, June 18, 2018 (GLOBE NEWSWIRE) -- Silexica will launch a new solution within SLX to support the increasing use of FPGAs for embedded computing tasks such as sensor fusion and deep learning. It has been developed in partnership with Ricoh and other customers who will use the solution for industrial automation and defense projects. The technology will be presented at Silexica's first appearance one of the world's biggest avionics exhibitions - AEE held in Munich from June 19-20. The

Immunicum AB (publ) meddelar publicering av en översiktsartikel kring ilixadencel-konceptet i Pharmaceutical Research18.6.2018 14:00Pressmeddelande

Pressmeddelande 18 juni 2018 Immunicum AB (publ) meddelar publicering av en översiktsartikel kring ilixadencel-konceptet i Pharmaceutical Research Immunicum AB (publ; IMMU.ST) offentliggjorde i dag online-publiceringen av en översiktsartikel av den senaste tidens utveckling inom immunonkologiforskning, med särskilt fokus på tidigare publicerade data som stöder värdet av bolagets ledande program, ilixadencel. Artikeln, med titeln "Ilixadencel - An Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration" publicerades on-line i Pharmaceutical Research , American Association of Pharmaceutical Scientists officiella tidskrift. Artikeln finns via följande länk https://link.springer.com/article/10.1007/s11095-018-2438-x - Det är en ära för vårt forsknings- och utvecklingsteam på Immunicum att bli erbjudna att skriva denna omfattande översikt som tar upp ilixadencels verkningsmekanism mot bakrund av de senaste upptäckterna gällande immunaktivering mot cancer. Våra preklin

Goldman Sachs and Cisco to Host Tech Talk on Data Center Networking18.6.2018 14:00Pressmeddelande

SAN JOSE, Calif., June 18, 2018 (GLOBE NEWSWIRE) -- Cisco will host a conference call with Goldman Sachs and Cisco's Ish Limkakeng, SVP, Product Management, Data Center Networking Group. The discussion will focus on Cisco's data center networking strategy, comprehensive portfolio, and its competitive advantage as customers seek highly secure and differentiated offerings. Interested parties can find more information on Cisco's Investor Relations website at https://investor.cisco.com. No new financial information will be discussed on this conference call. Date: Thursday, June 21, 2018 Time: 8:30 am PT / 11:30 am ET Speaker: Ish Limkakeng, SVP, Product Management, Data Center Networking Group Moderator: Goldman Sachs' Rod Hall, Managing Director Participant Dial in: Toll Free: 877-208-2954 International Number: 973-528-0056 Passcode: 201872 Replay Information (available until July 5, 2018): Toll Free: 800-332-6854 International Number: 973-528-0005 Passcode: 201872 This event will be webc

Immunicum AB (publ) Announces Publication of Scientific Review of Ilixadencel Approach in Pharmaceutical Research18.6.2018 14:00Pressmeddelande

Press Release 18 June 2018 Immunicum AB (publ) Announces Publication of Scientific Review of Ilixadencel Approach in Pharmaceutical Research Immunicum AB (publ; IMMU.ST) announced today the online publication of a review article providing an overview of recent developments in immuno-oncology research, specifically focusing on previously published data supporting the value of its lead program, ilixadencel. The article, titled "Ilixadencel - An Allogeneic Cell-Based Anticancer Immune Primer for Intratumoral Administration", was published in Pharmaceutical Research , the official journal of the American Association of Pharmaceutical Scientists. The article can be accessed via the following link https://link.springer.com/article/10.1007/s11095-018-2438-x "It is an honor for our research and development team at Immunicum to be invited to write this in-depth review article covering ilixadencel's mode of action in context of the most recent discoveries in anti-cancer immune activation," comme

DSM Sinochem Pharmaceuticals launches Atorvastatin film-coated tablets, expanding its finished dosage statins portfolio18.6.2018 11:23Pressmeddelande

Rijswijk, 18 June 2018, June 18, 2018 (GLOBE NEWSWIRE) -- Building upon its first generic finished dosage statin launch (Rosuvastatin) in January of this year, DSM Sinochem Pharmaceuticals (DSP) has this month released its fully backward-integrated, generic Atorvastatin drug product within the EU. Additional markets are scheduled to follow later in the year.Atorvastatin is used primarily in the prevention of cardiovascular disease and hyperlipidemia, commonly known as high cholesterol, the number one cause of death worldwide. Currently, statins are the most prescribed drug family globally in the fight against these potentially life-threatening conditions. Expanding statins portfolio With the launch now of Atorvastatin finished dosage formulation, coming on the heels of the successful launch of Rosuvastatin in January of 2018, DSP is actively expanding its statins drug product portfolio, realizing its aspiration of becoming a full-service generics pharmaceutical company. What sets DSP a

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum